4//SEC Filing
Snyder Mark Howard 4
Accession 0001415889-25-017270
CIK 0001159036other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:33 PM ET
Size
8.7 KB
Accession
0001415889-25-017270
Insider Transaction Report
Form 4
Snyder Mark Howard
SVP, CHIEF LEGAL OFFICER
Transactions
- Tax Payment
Common Stock
2025-06-12$54.54/sh−2,711$147,858→ 30,813 total - Exercise/Conversion
Restricted Stock Units
2025-06-12−5,035→ 15,102 totalExercise: $0.00→ Common Stock (5,035 underlying) - Exercise/Conversion
Common Stock
2025-06-12+5,035→ 33,524 total
Footnotes (2)
- [F1]The reported disposition of 2,711 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001902866
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 5:33 PM ET
- Size
- 8.7 KB